| 摘要 |
The present disclosure is directed to benzamide derivatives of formula (I), wherein the variables are as defined in the specification. These compounds inhibit the purinergic 2X7 (P2X7) receptor, and pharmaceutical compositions comprising said compounds are useful for treating pain, inflammation, neurological disorders, or neuropsychiatric disorders. |
